Literature DB >> 8401632

Prognostic factors in superficial bladder cancer.

D K Chopin1, Z Popov, V Ravery, J Bellot, A Hoznek, J J Patard, C C Abbou, M Colombel.   

Abstract

A large body of evidence suggests that intravesical prophylaxis using bacillus Calmette-Guérin can favorably alter the natural history of superficial bladder cancer. The search for prognostic factors impacting the clinical alternative between conservative and radical treatment has been the subject of numerous efforts and remains a major objective in improving the carcinological results and the quality of life patients with superficial bladder cancer. In this regard, information is available on three levels: clinicopathological parameters, quantitative analysis, and biological markers. Recent advances in as well as the limitations and pitfalls of the use of three kinds of information in prognostication are reviewed. The proper use of prognostic factors will modify our attitude toward superficial bladder cancer in the near future.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401632     DOI: 10.1007/bf00211409

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  45 in total

1.  The epidermal growth factor receptor and the prognosis of bladder cancer.

Authors:  D E Neal; L Sharples; K Smith; J Fennelly; R R Hall; A L Harris
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

2.  Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.

Authors:  K Okamura; K Miyake; T Koshikawa; J Asai
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

3.  Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Authors:  M K Parmar; L S Freedman; T B Hargreave; D A Tolley
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

4.  An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.

Authors:  K Sato; M Moriyama; S Mori; M Saito; T Watanuki; K Terada; E Okuhara; T Akiyama; K Toyoshima; T Yamamoto
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

5.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

Authors:  W Lutzeyer; H Rübben; H Dahm
Journal:  J Urol       Date:  1982-02       Impact factor: 7.450

6.  Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

Authors:  Y C Tsai; P W Nichols; A L Hiti; Z Williams; D G Skinner; P A Jones
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

7.  Superficial bladder cancer: progression and recurrence.

Authors:  N M Heney; S Ahmed; M J Flanagan; W Frable; M P Corder; M D Hafermann; I R Hawkins
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

8.  Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients.

Authors:  M Tachibana; N Deguchi; S Baba; S Jitsukawa; M Hata; H Tazaki
Journal:  J Urol       Date:  1991-12       Impact factor: 7.450

9.  Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas.

Authors:  W M Murphy; R W Chandler; R M Trafford
Journal:  J Urol       Date:  1986-04       Impact factor: 7.450

10.  Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Authors:  A S Sarkis; G Dalbagni; C Cordon-Cardo; Z F Zhang; J Sheinfeld; W R Fair; H W Herr; V E Reuter
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

View more
  2 in total

1.  Molecular expression profiling with respect to KEGG hsa05219 pathway.

Authors:  Raghavendra Krishnappa
Journal:  Ecancermedicalscience       Date:  2011-02-22

2.  Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.

Authors:  Hans Olsson; Per Hultman; Nastaran Monsef; Johan Rosell; Staffan Jahnson
Journal:  ISRN Urol       Date:  2012-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.